| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,819 |
2,387 |
$168K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
481 |
464 |
$65K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
591 |
567 |
$59K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
609 |
607 |
$49K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
626 |
575 |
$48K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,303 |
1,234 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
200 |
192 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
195 |
183 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
44 |
44 |
$6K |
| 90674 |
|
106 |
106 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
140 |
139 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
147 |
142 |
$2K |
| 99050 |
|
713 |
598 |
$851.41 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
104 |
50 |
$819.78 |
| 0124A |
|
26 |
26 |
$786.72 |
| 90658 |
|
35 |
35 |
$559.42 |
| 93000 |
|
25 |
25 |
$323.38 |
| 87428 |
|
16 |
16 |
$213.06 |
| 36415 |
Collection of venous blood by venipuncture |
225 |
223 |
$121.20 |
| 99051 |
|
138 |
112 |
$117.04 |
| 91312 |
|
27 |
27 |
$16.56 |